NASDAQ: NEPH - Nephros, Inc.

Rentabilidade por seis meses: -27.67%
Setor: Healthcare

Cronograma de promoção Nephros, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Nephros, Inc. engages in development and sale of high performance water solutions to the medical and commercial markets in the United States. The company operates in two segments: Water Filtration and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.

mais detalhes
The company also develops and sells medical device products for patients with renal disease, including a second generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it manufactures and sells water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and Nanoguard brands for the food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2004-09-21
ISIN US6406714005
Industry Household Durables
Sector Consumer Discretionary
Валюта usd
Валюта отчета usd
Сайт https://www.nephros.com
Цена ао 2.21
Alteração de preço por dia: +0.6757% (1.48)
Alteração de preço por semana: -3.25% (1.54)
Alteração de preço por mês: -1.32% (1.51)
Alteração de preço em 3 meses: -12.87% (1.71)
Mudança de preço em seis meses: -27.67% (2.06)
Mudança de preço por ano: -56.94% (3.46)
Mudança de preço em 3 anos: -77.46% (6.61)
Mudança de preço em 5 anos: -81.83% (8.2)
Mudança de preço em 10 anos: 0% (1.49)
Mudança de preço desde o início do ano: -3.87% (1.55)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 2.25 6
P/BV 3.84 4
P/E 0 0
EV/EBITDA -21.48 0
Total: 3.5

Eficiência

Nome Significado Nota
ROA, % -13.28 0
ROE, % -18.84 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -1.33 10
Total: 9.4

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 38.23 5
Rentabilidade Ebitda, % -56.91 0
Rentabilidade EPS, % -64.02 0
Total: 1
Mais detalhes

Instituições Volume Compartilhar, %
Wexford Capital LP 3682724 48
Bard Associates Inc. 187318 2.44
Vanguard Group Inc 171310 2.23
Geode Capital Management, LLC 71037 0.93
HighTower Advisors, LLC 56710 0.74
Blair (William) & Company, L.L.C. 36249 0.47
Morgan Stanley 33774 0.44
Elkhorn Partners Limited Partnership 31900 0.42
State Street Corporation 15698 0.2
Mesirow Financial Investment Management, Inc. 15383 0.2

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Dimensional U.S. Core Equity 2 ETF 0 30.76 1.47098



Supervisor Cargo Pagamento Ano de nascimento
Mr. Robert Banks President, CEO & Director 474.04k 1975 (50 anos)
Ms. Judy F. Krandel C.F.A. Chief Financial Officer 147.01k 1965 (60 anos)
Brianne McGuire Director of Brand, Marketing & Business Development N/A
Vashone R. Thomas Vice President of Quality, Regulatory, & Human Resources N/A
Mr. Greg Lucas President of Aether Water Systems N/A
Ms. Judy Mazzini Controller N/A
Mr. Alfred Vargas Director of Operations N/A
Mr. Daron G. Evans M.B.A., M.S. Chief Executive Officer of Specialty Renal Products, Inc 300.18k 1974 (51 ano)

Endereço: United States, South Orange. NJ, 380 Lackawanna Place - abrir no Google Maps, abrir mapas Yandex
Site: https://www.nephros.com